Search Results

There are 2968682 results for: content related to: Doxorubicin-induced cardiomyopathy treated with carvedilol

  1. Carvedilol: A Novel Cardiovascular Drug with Multiple Actions

    Cardiovascular Drug Reviews

    Volume 10, Issue 2, June 1992, Pages: 127–157, Robert R. Ruffolo Jr., Duane A. Boyle, David P. Brooks, Giora Z. Feuerstein, Robert P. Venuti, Mary Ann Lukas and George Poste

    Article first published online : 2 APR 2007, DOI: 10.1111/j.1527-3466.1992.tb00242.x

  2. Analysis of carvedilol enantiomers in human plasma using chiral stationary phase column and liquid chromatography with tandem mass spectrometry

    Chirality

    Volume 24, Issue 3, March 2012, Pages: 209–214, Josiane Cristófani Poggi, Flávia Garcez Da Silva, Eduardo Barbosa Coelho, Maria Paula Marques, Carlo Bertucci and Vera Lucia Lanchote

    Article first published online : 24 JAN 2012, DOI: 10.1002/chir.21984

  3. Mechanism of carvedilol-induced block of delayed rectifier K+ current in the NG108-15 neuronal cell line

    Drug Development Research

    Volume 58, Issue 2, February 2003, Pages: 196–208, Chun-Peng Liu, Hung-Ting Chiang, Chung-Ren Jan and Sheng-Nan Wu

    Article first published online : 27 MAR 2003, DOI: 10.1002/ddr.10165

  4. You have free access to this content
    Carvedilol: Molecular and Cellular Basis for Its Multifaceted Therapeutic Potential

    Cardiovascular Drug Reviews

    Volume 19, Issue 2, June 2001, Pages: 152–171, Jianhua Cheng, Kaichiro Kamiya and Itsuo Kodama

    Article first published online : 7 JUN 2006, DOI: 10.1111/j.1527-3466.2001.tb00061.x

  5. Doxorubicin-Induced Cardiotoxicity: From Bioenergetic Failure and Cell Death to Cardiomyopathy

    Medicinal Research Reviews

    Volume 34, Issue 1, January 2014, Pages: 106–135, Filipa S. Carvalho, Ana Burgeiro, Rita Garcia, António J. Moreno, Rui A. Carvalho and Paulo J. Oliveira

    Article first published online : 11 MAR 2013, DOI: 10.1002/med.21280

  6. Ethanol Does Not Alter the Pharmacokinetic Profile of the Controlled-release Formulation of Carvedilol

    The Journal of Clinical Pharmacology

    Volume 47, Issue 11, November 2007, Pages: 1358–1365, Dr Linda S. Henderson, Dr David M. Tenero, Ms Andrea M. Campanile, Charlotte A. Baidoo and Dr Theodore M. Danoff

    Article first published online : 7 MAR 2013, DOI: 10.1177/0091270007307244

  7. Carvedilol promotes neurological function, reduces bone loss and attenuates cell damage after acute spinal cord injury in rats

    Clinical and Experimental Pharmacology and Physiology

    Volume 42, Issue 2, February 2015, Pages: 202–212, Da Liu, Ying Huang, Bin Li, Changqing Jia, Feng Liang and Qin Fu

    Article first published online : 12 JAN 2015, DOI: 10.1111/1440-1681.12345

  8. Stereoselective effects of (R)- and (S)-carvedilol in humans

    Chirality

    Volume 13, Issue 7, 2001, Pages: 342–346, Kurt Stoschitzky, Gergana Koshucharova, Peter Lercher, Robert Maier, Andrea Sakotnik, Werner Klein, Peter M. Liebmann and Wolfgang Lindner

    Article first published online : 22 JUN 2001, DOI: 10.1002/chir.1042

  9. You have free access to this content
    Modulation of K2P2.1 and K2P10.1 K+ channel sensitivity to carvedilol by alternative mRNA translation initiation

    British Journal of Pharmacology

    Volume 171, Issue 23, December 2014, Pages: 5182–5194, J Kisselbach, C Seyler, P A Schweizer, R Gerstberger, R Becker, H A Katus and D Thomas

    Article first published online : 28 AUG 2014, DOI: 10.1111/bph.12596

  10. Evaluation of Carvedilol for the Treatment of Portal Hypertension

    Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy

    Volume 24, Issue 1, January 2004, Pages: 94–104, Brian A. Hemstreet

    Article first published online : 16 JAN 2012, DOI: 10.1592/phco.24.1.94.34805

  11. Carvedilol: A Novel Multiple Action Antihypertensive Drug that Provides Major Organ Protection

    Cardiovascular Drug Reviews

    Volume 12, Issue 2, June 1994, Pages: 85–104, Giora Feuerstein, Tian-Li Yue, XinLiang Ma and Robert Ruffolo Jr.

    Article first published online : 2 APR 2007, DOI: 10.1111/j.1527-3466.1994.tb00285.x

  12. Critical Differences Among Beta-Adrenoreceptor Antagonists in Myocardial Failure: Debating the MERIT of COMET

    The Journal of Clinical Pharmacology

    Volume 45, Issue 1, January 2005, Pages: 6–24, Dr Brian F. McBride and Dr C. Michael White

    Article first published online : 7 MAR 2013, DOI: 10.1177/0091270004269841

  13. You have free access to this content
    Carvedilol in the failing heart

    Clinical Cardiology

    Volume 24, Issue 12, December 2001, Pages: 757–766, William L. Lombardi and Edward M. Gilbert

    Article first published online : 3 FEB 2009, DOI: 10.1002/clc.4960241202

  14. You have free access to this content
    Randomized controlled trial of carvedilol versus variceal band ligation for the prevention of the first variceal bleed

    Hepatology

    Volume 50, Issue 3, September 2009, Pages: 825–833, Dhiraj Tripathi, James W. Ferguson, Narendra Kochar, Joanna A. Leithead, George Therapondos, Norma C. Mcavoy, Adrian J. Stanley, Ewan H. Forrest, William S. Hislop, Peter R. Mills and Peter C. Hayes

    Article first published online : 24 APR 2009, DOI: 10.1002/hep.23045

  15. You have free access to this content
    Addition of N-Acetyl Cysteine to Carvedilol Decreases the Incidence of Acute Renal Injury After Cardiac Surgery

    Clinical Cardiology

    Volume 37, Issue 2, February 2014, Pages: 108–114, Mehmet Ozaydin, Tulay Peker, Selahaddin Akcay, Bayram A. Uysal, Habil Yucel, Atilla Icli, Dogan Erdogan, Ercan Varol, Abdullah Dogan and Huseyin Okutan

    Article first published online : 25 NOV 2013, DOI: 10.1002/clc.22227

  16. You have free access to this content
    Oxidative Status, Inflammation, and Postoperative Atrial Fibrillation With Metoprolol vs Carvedilol or Carvedilol Plus N-Acetyl Cysteine Treatment

    Clinical Cardiology

    Volume 37, Issue 5, May 2014, Pages: 300–306, Mehmet Ozaydin, Oktay Peker, Dogan Erdogan, Selahaddin Akcay, Habil Yucel, Atilla Icli, Betul M. Ceyhan, Recep Sutcu, Bayram A. Uysal, Ercan Varol, Abdullah Dogan and Huseyin Okutan

    Article first published online : 29 JAN 2014, DOI: 10.1002/clc.22249

  17. You have free access to this content
    Effects of carvedilol on heart failure with preserved ejection fraction: the Japanese Diastolic Heart Failure Study (J-DHF)

    European Journal of Heart Failure

    Volume 15, Issue 1, January 2013, Pages: 110–118, Kazuhiro Yamamoto, Hideki Origasa, Masatsugu Hori and on behalf of the J-DHF Investigators

    Article first published online : 27 JAN 2014, DOI: 10.1093/eurjhf/hfs141

  18. Clinical pharmacology of carvedilol in normal volunteers

    Clinical Pharmacology & Therapeutics

    Volume 41, Issue 1, January 1987, Pages: 31–44, Luigi X Cubeddu, Nery Fuenmayor, France Varin, Victor G Villagra, Romulo E Colindres and J Robert Powell

    Article first published online : 15 JAN 1987, DOI: 10.1038/clpt.1987.6

  19. You have free access to this content
    Carvedilol's antiarrhythmic properties: Therapeutic implications in patients with left ventricular dysfunction

    Clinical Cardiology

    Volume 28, Issue 4, April 2005, Pages: 165–173, Gerald V. Naccarelli and Mary Ann Lukas

    Article first published online : 5 DEC 2006, DOI: 10.1002/clc.4960280403

  20. You have free access to this content
    Carvedilol targets human K2P3.1 (TASK1) K+ leak channels

    British Journal of Pharmacology

    Volume 163, Issue 5, July 2011, Pages: 1099–1110, K Staudacher, I Staudacher, E Ficker, C Seyler, J Gierten, J Kisselbach, A-K Rahm, K Trappe, PA Schweizer, R Becker, HA Katus and D Thomas

    Article first published online : 8 JUN 2011, DOI: 10.1111/j.1476-5381.2011.01319.x